Patents Assigned to LFB SA
  • Patent number: 7932355
    Abstract: La present invention pertains to a composition of plasma-derived virally-safe factor VIII, obtained after nanometric filtration, said composition comprising von Willebrand factor (vWF) at a rate of 15% or less of decamers and higher multimers. Such compositions have a reduction factor of the virus titre higher than 4 log and are thus suitable for treatment of hemophilia.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: April 26, 2011
    Assignee: LFB SA
    Inventors: Abdessatar Chtourou, Michel Nogre, Roland Schmitthaeusler